Difference between revisions of "Pan S, et al. ACS Med. Chem. Lett. (2010) cited as Ref 611 in DOI: 10.1038/s41392-020-0110-5 (Q9874)"
Jump to navigation
Jump to search
(Created claim: title (P93): Discovery of NVP-LDE225 a potent and selective smoothened antagonist, #quickstatements; #temporary_batch_1590010982689) |
(Created claim: Page(s) (P105): 130-134, #quickstatements; #temporary_batch_1590074839150) |
||
| Property / Page(s) | |||
| + | 130-134 | ||
| Property / Page(s): 130-134 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:47, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Pan S, et al. ACS Med. Chem. Lett. (2010) cited as Ref 611 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Pan S
0 references
2010
0 references
ACS Med. Chem. Lett.
0 references
1
0 references
Discovery of NVP-LDE225 a potent and selective smoothened antagonist (English)
0 references
130-134
0 references
